Nicolas Congy‐Jolivet

1.0k total citations
48 papers, 554 citations indexed

About

Nicolas Congy‐Jolivet is a scholar working on Immunology, Transplantation and Surgery. According to data from OpenAlex, Nicolas Congy‐Jolivet has authored 48 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 20 papers in Transplantation and 12 papers in Surgery. Recurrent topics in Nicolas Congy‐Jolivet's work include Renal Transplantation Outcomes and Treatments (20 papers), T-cell and B-cell Immunology (17 papers) and Immune Cell Function and Interaction (15 papers). Nicolas Congy‐Jolivet is often cited by papers focused on Renal Transplantation Outcomes and Treatments (20 papers), T-cell and B-cell Immunology (17 papers) and Immune Cell Function and Interaction (15 papers). Nicolas Congy‐Jolivet collaborates with scholars based in France, Japan and United Kingdom. Nicolas Congy‐Jolivet's co-authors include Nassim Kamar, Arnaud Del Bello, Laure Esposito, Antoine Blancher, Marie Danjoux, Bénédicte Puissant‐Lubrano, Fabrice Muscari, P.A. Apoil, Laurence Lavayssière and Lionel Rostaing and has published in prestigious journals such as Scientific Reports, Kidney International and Frontiers in Immunology.

In The Last Decade

Nicolas Congy‐Jolivet

46 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Congy‐Jolivet France 14 279 189 159 82 74 48 554
Jun B. Lee United States 7 318 1.1× 194 1.0× 188 1.2× 25 0.3× 85 1.1× 9 585
Johan Noble France 16 340 1.2× 171 0.9× 129 0.8× 32 0.4× 131 1.8× 78 641
Nancy Higgins United States 14 274 1.0× 208 1.1× 115 0.7× 37 0.5× 96 1.3× 25 480
C. Schönemann Germany 11 471 1.7× 280 1.5× 205 1.3× 48 0.6× 159 2.1× 31 658
Irena Brabcová Czechia 13 238 0.9× 145 0.8× 120 0.8× 33 0.4× 64 0.9× 20 434
Lucile Amrouche France 13 374 1.3× 263 1.4× 101 0.6× 27 0.3× 148 2.0× 32 674
Matthias Büchler France 9 211 0.8× 97 0.5× 119 0.7× 119 1.5× 141 1.9× 20 567
M.L. Farrell United States 8 280 1.0× 205 1.1× 138 0.9× 82 1.0× 134 1.8× 11 546
A. Zeevi United States 16 355 1.3× 334 1.8× 168 1.1× 102 1.2× 154 2.1× 34 705
Hussein Sheashaa Egypt 13 200 0.7× 132 0.7× 111 0.7× 30 0.4× 52 0.7× 31 591

Countries citing papers authored by Nicolas Congy‐Jolivet

Since Specialization
Citations

This map shows the geographic impact of Nicolas Congy‐Jolivet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Congy‐Jolivet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Congy‐Jolivet more than expected).

Fields of papers citing papers by Nicolas Congy‐Jolivet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Congy‐Jolivet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Congy‐Jolivet. The network helps show where Nicolas Congy‐Jolivet may publish in the future.

Co-authorship network of co-authors of Nicolas Congy‐Jolivet

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Congy‐Jolivet. A scholar is included among the top collaborators of Nicolas Congy‐Jolivet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Congy‐Jolivet. Nicolas Congy‐Jolivet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fort, Marylise, et al.. (2025). Identification of the Novel HLA‐A*02:540:02N Allele by Next‐Generation Sequencing. HLA. 106(6). e70499–e70499.
2.
Congy‐Jolivet, Nicolas, et al.. (2025). Identification of the Novel HLA‐DRB3*02:213 Allele by Next‐Generation Sequencing. HLA. 105(2). e70002–e70002. 1 indexed citations
3.
Renaudineau, Yves, Amandine Charras, Nicolas Congy‐Jolivet, et al.. (2025). Across ancestries, HLA-B∗08:01∼DRB1∗03:01 (DR3) and HLA-DQA∗01:02 (DR2) increase the risk to develop juvenile-onset systemic lupus erythematosus through low complement C4 levels. Journal of Translational Autoimmunity. 10. 100268–100268. 3 indexed citations
4.
Cargou, Marine, et al.. (2024). Identification of the novel HLA‐DRB1*14:253 allele by next‐generation sequencing. HLA. 103(2). e15389–e15389. 2 indexed citations
5.
Congy‐Jolivet, Nicolas, et al.. (2024). Utility of Routine Post Kidney Transplant Anti-HLA Antibody Screening. Kidney International Reports. 9(5). 1343–1353. 2 indexed citations
6.
Cargou, Marine, et al.. (2024). Identification of the novel HLA‐DQA1*02:32 allele by next‐generation sequencing. HLA. 103(5). e15512–e15512. 1 indexed citations
7.
Girard, C., et al.. (2023). Accuracy of Serological Screening for the Diagnosis of Celiac Disease in Type 1 Diabetes Children. Medicina. 59(7). 1321–1321. 3 indexed citations
8.
Cargou, Marine, et al.. (2023). Identification of the novel HLA‐C*03:632 allele by next‐generation sequencing. HLA. 102(1). 92–93. 1 indexed citations
9.
Congy‐Jolivet, Nicolas, et al.. (2023). Characterization of the novel HLA‐DRB3*02:193 allele by sequencing‐based typing. HLA. 102(5). 641–643. 2 indexed citations
10.
Meszaros, Magdalena, Valérie Dubois, Nicolas Congy‐Jolivet, et al.. (2022). Impact of calcineurin inhibitor‐free immunosuppression on de novo donor‐specific antibody formation in liver transplant recipients. Liver International. 42(5). 1132–1143. 5 indexed citations
11.
Puissant‐Lubrano, Bénédicte, Nicolas Congy‐Jolivet, Vincent Minville, et al.. (2022). The oxygen carrier M101 alleviates complement activation, which may be beneficial for donor organ preservation. Frontiers in Immunology. 13. 1006761–1006761. 9 indexed citations
12.
Cargou, Marine, et al.. (2021). Identification of the novel HLA‐DPA1*01:49 allele by next‐generation sequencing. HLA. 98(3). 251–252. 2 indexed citations
13.
Congy‐Jolivet, Nicolas, Laure Esposito, Olivier Marion, et al.. (2020). Do anti-IL-6R blockers have a beneficial effect in the treatment of antibody-mediated rejection resistant to standard therapy after kidney transplantation?. American Journal of Transplantation. 21(4). 1641–1649. 34 indexed citations
14.
Kamar, Nassim, Benoît Lepage, Lionel Couzi, et al.. (2020). A Randomized Prospective Study Comparing Anti–T-Lymphocyte Igs to Basiliximab in Highly Sensitized Kidney Transplant Patients. Kidney International Reports. 5(8). 1207–1217. 3 indexed citations
15.
Visentin, Jonathan, Thomas Bachelet, Olivier Aubert, et al.. (2019). Reassessment of the clinical impact of preformed donor-specific anti-HLA-Cw antibodies in kidney transplantation. American Journal of Transplantation. 20(5). 1365–1374. 20 indexed citations
16.
Bello, Arnaud Del, Martine Neau‐Cransac, Laurence Lavayssière, et al.. (2019). Outcome of Liver Transplant Patients With Preformed Donor‐Specific Anti–Human Leukocyte Antigen Antibodies. Liver Transplantation. 26(2). 256–267. 18 indexed citations
17.
Bello, Arnaud Del, Gillian Divard, Julie Bellière, et al.. (2019). Anti‐IL‐2R blockers comparing with polyclonal antibodies: Higher risk of rejection without negative mid‐term outcomes after ABO‐incompatible kidney transplantation. Clinical Transplantation. 33(10). e13681–e13681. 5 indexed citations
18.
Apoil, P.A., Bénédicte Puissant‐Lubrano, Nicolas Congy‐Jolivet, et al.. (2017). Influence of age, sex and HCMV-serostatus on blood lymphocyte subpopulations in healthy adults. Cellular Immunology. 314. 42–53. 28 indexed citations
19.
Bello, Arnaud Del, Nicolas Congy‐Jolivet, Marie Danjoux, Fabrice Muscari, & Nassim Kamar. (2016). Donor-specific antibodies and liver transplantation. Human Immunology. 77(11). 1063–1070. 39 indexed citations
20.
Congy‐Jolivet, Nicolas, Arnaud Del Bello, Katy Trébern-Launay, et al.. (2016). Impact of Early Blood Transfusion After Kidney Transplantation on the Incidence of Donor-Specific Anti-LA Antibodies. American Journal of Transplantation. 16(9). 2661–2669. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun B. Lee Breakdown of academic impact, for papers by Johan Noble Breakdown of academic impact, for papers by Nancy Higgins Breakdown of academic impact, for papers by C. Schönemann Breakdown of academic impact, for papers by Irena Brabcová Breakdown of academic impact, for papers by Lucile Amrouche Breakdown of academic impact, for papers by Matthias Büchler Breakdown of academic impact, for papers by M.L. Farrell Breakdown of academic impact, for papers by A. Zeevi Breakdown of academic impact, for papers by Hussein Sheashaa
Rankless by CCL
2026